Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck

Carcinogenesis

Volumn 31, Issue 11, 2010, Pages 1977-1981

  Liu, Zhensheng ^a   Li, Guojun ^a   Wei, Sheng ^a   Niu, Jiangong ^a   Wang, Li E ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLEFT LIP AND PALATE TRANSMEMBRANE 1 LIKE PROTEIN; CYSTEINE; PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DNA POLYMORPHISM; DRINKING BEHAVIOR; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; GENETIC VARIATION; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMOKING; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 78149273493     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq179     Document Type: Article

References (31)

1. Weinrich, S.L. et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet., 17, 498-502.
2. Cong, Y.S. et al. (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet., 8, 137-142.
3. Cheung, A.L. et al. (2008) Telomere dysfunction, genome instability and cancer. Front. Biosci., 13, 2075-2090.
4. Jefford, C.E. et al. (2006) Mechanisms of chromosome instability in cancers. Crit. Rev. Oncol. Hematol., 59, 1-14.
5. Wick, M. et al. (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 232, 97-106.
6. Bryce, L.A. et al. (2000) Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p.15.33 by fluorescence in situ hybridization. Neoplasia, 2, 197-201.
7. Wang, S. et al. (2004) The hTERT gene is embedded in a nuclease-resistant chromatin domain. J. Biol. Chem., 279, 55401-55410.
8. Hiyama, E. et al. (1995) Telomerase activity in gastric cancer. Cancer Res., 55, 3258-3262.
9. Clark, G.M. et al. (1997) Telomerase activity and survival of patients with node-positive breast cancer. J. Natl Cancer Inst., 89, 1874-1881.
10. Wisman, G.B. et al. (2000) Telomerase in (pre)neoplastic cervical disease. Hum. Pathol., 31, 1304-1312.
11. Tatsumoto, N. et al. (2000) High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin. Cancer. Res., 6, 2696-2701.
12. Falchetti, M.L. et al. (2000) In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int. J. Cancer, 88, 895-901.
13. Wang, L. et al. (2002) hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin. Cancer Res., 8, 2883-2889.
14. Kim, H.R. et al. (2001) Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin. Cancer Res., 7, 3079-3086.
15. Zienolddiny, S. et al. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis, 30, 1368-1371.
16. McKay, J.D. et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
17. Wang, Y. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
18. Rafnar, T. et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
19. Stacey, S.N. et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet., 41, 909-914.
20. Parkin, D.M. et al. (2001) Estimating the world cancer burden: Globocan 2000. Int. J. Cancer, 94, 153-156.
21. Jemal, A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
22. Sturgis, E.M. et al. (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer, 110, 1429-1435.
23. Ryerson, A.B. et al. (2008) Burden of potentially human papillomavirusassociated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer, 113, 2901-2909.
24. Colombo, J. et al. (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncol. Rep., 21, 649-663.
25. Liu, Z. et al. (2008) Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett., 268, 158-165.
26. Bagheri, S. et al. (2006) Genes and pathways downstream of telomerase in melanoma metastasis. Proc. Natl Acad. Sci. USA, 103, 11306-11311.
27. Nosrati, M. et al. (2004) Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clin. Cancer Res., 10, 4983-4990.
28. Savage, S.A. et al. (2007) Genetic variation in five genes important in telomere biology and risk for breast cancer. Br. J. Cancer, 97, 832-836.
29. Choi, J.E. et al. (2009) Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol. Biomarkers Prev., 18, 2773-2781.
30. Yamamoto, K. et al. (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun., 280, 1148-1154.
31. Asakura, T. et al. (2005) Relationship between expression of drugresistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Oncol. Rep., 14, 601-607.